<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.ajronline.org">
<title>American Journal of Roentgenology current issue</title>
<link>http://www.ajronline.org</link>
<description>American Journal of Roentgenology RSS feed -- current issue</description>
<prism:eIssn>1546-3141</prism:eIssn>
<prism:coverDisplayDate>Dec  1 2009 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>American Journal of Roentgenology</prism:publicationName>
<prism:issn>0361-803X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/W472?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W478?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W482?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W490?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W505?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W515?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W523?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W530?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W540?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W546?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W558?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W563?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/W567?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/W568?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/W569?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/1471?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/1475?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/1481?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/1486?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1488?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1494?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1500?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1504?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1514?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1522?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1531?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1540?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1546?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1556?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1561?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1568?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1576?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1593?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1596?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1603?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1607?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1615?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1621?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1629?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1640?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1648?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1656?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1665?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1672?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1680?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1686?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1691?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1696?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1703?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1708?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1716?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1723?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1731?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1738?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.ajronline.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.ajronline.org/icons/banner/title.gif">
<title>American Journal of Roentgenology</title>
<url>http://www.ajronline.org/icons/banner/title.gif</url>
<link>http://www.ajronline.org</link>
</image>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/W472?rss=1">
<title><![CDATA[Tree-In-Bud Pattern]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/W472?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Gosset, N., Bankier, A. A., Eisenberg, R. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3401</dc:identifier>
<dc:title><![CDATA[Tree-In-Bud Pattern]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W477</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W472</prism:startingPage>
<prism:section>Residents' Section</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W478?rss=1">
<title><![CDATA[Coronary Abnormalities in Hyper-IgE Recurrent Infection Syndrome: Depiction at Coronary MDCT Angiography]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W478?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Hyper-IgE recurrent infection syndrome (HIES or Job's
syndrome) is a rare disorder affecting the immune system and connective
tissues. The purpose of this study is to describe the coronary abnormalities
in genetically confirmed HIES patients as depicted by coronary MDCT
angiography (MDCTA).</p>
<p><b>CONCLUSION.</b> Coronary MDCTA has provided an opportunity for
noninvasive evaluation of the coronary arteries in patients with HIES. These
coronary abnormalities vary from tortuosity to ectatic dilation and focal
aneurysms of the coronary arteries. Such an evaluation has potential value in
identifying new aspects of this disease and thereby providing better
understanding of the pathophysiology of the disorder.</p>
]]></description>
<dc:creator><![CDATA[Gharib, A. M., Pettigrew, R. I., Elagha, A., Hsu, A., Welch, P., Holland, S. M., Freeman, A. F.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2623</dc:identifier>
<dc:title><![CDATA[Coronary Abnormalities in Hyper-IgE Recurrent Infection Syndrome: Depiction at Coronary MDCT Angiography]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W481</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W478</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W482?rss=1">
<title><![CDATA[Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W482?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate according to
size and degree of cellular differentiation the multiphasic MDCT enhancement
pattern of hepatocellular carcinoma (HCC) smaller than 3 cm in diameter in
patients with cirrhosis.</p>
<p><b>MATERIALS AND METHODS.</b> In 155 consecutively registered patients (126
men, 29 women; mean age, 58.4 years), 204 pathologically proven HCCs smaller
than 3 cm were detected at multiphasic MDCT. Three radiologists in consensus
classified the relative attenuation of the tumors compared with the
surrounding liver parenchyma as hyperattenuation, isoattenuation, or
hypoattenuation on biphasic (<I>n</I> = 86) and triphasic (<I>n</I> = 69)
CT scans.</p>
<p><b>RESULTS.</b> The prevalent enhancement patterns of HCC differed
depending on tumor size. The prevalent pattern of HCC measuring 20&ndash;29 mm
was arterial hyperattenuation with venous washout (47%, 47/101). The prevalent
enhancement patterns of HCC smaller than 10 mm and HCC measuring 10&ndash;19
mm were isoattenuation during the arterial and portal venous phases (29%,
6/21) and hyperattenuation and isoattenuation during the arterial and portal
venous phases (33%, 27/82). The typical HCC enhancement pattern (arterial
hyperattenuation with venous washout) was identified in 48% (67/141) of the
moderately and poorly differentiated HCCs and in 13% (8/63) of
well-differentiated HCCs.</p>
<p><b>CONCLUSION.</b> The prevalent enhancement patterns of HCC smaller than 3
cm on multiphasic MDCT scans differed depending on tumor size and cellular
differentiation. HCCs smaller than 2 cm and well-differentiated HCCs
frequently had atypical enhancement patterns.</p>
]]></description>
<dc:creator><![CDATA[Yoon, S. H., Lee, J. M., So, Y. H., Hong, S. H., Kim, S. J., Han, J. K., Choi, B. I.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1818</dc:identifier>
<dc:title><![CDATA[Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W489</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W482</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W490?rss=1">
<title><![CDATA["Pseudo Washout" Sign in High-Flow Hepatic Hemangioma on Gadoxetic Acid Contrast-Enhanced MRI Mimicking Hypervascular Tumor]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W490?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to describe the
"pseudo washout" sign of high-flow hepatic hemangioma that mimics
hypervascular tumor on gadoxetic acid&ndash;enhanced MRI.</p>
<p><b>CONCLUSION.</b> High-flow hemangiomas might show relatively low signal
intensity because of gadoxetic acid contrast uptake in the surrounding normal
liver parenchyma during the equilibrium (3-minute delay) phase. Such findings
are called pseudo washout and can mimic hypervascular hepatic tumors. However,
high-flow hemangioma can be diagnosed by observing bright signal intensity on
T2-weighted imaging, arterial phase&ndash;dominant enhancement, pseudo washout
sign during the equilibrium phase, and isointense or slightly increased signal
intensity on subtraction images.</p>
]]></description>
<dc:creator><![CDATA[Doo, K. W., Lee, C. H., Choi, J. W., Lee, J., Kim, K. A., Park, C. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1732</dc:identifier>
<dc:title><![CDATA["Pseudo Washout" Sign in High-Flow Hepatic Hemangioma on Gadoxetic Acid Contrast-Enhanced MRI Mimicking Hypervascular Tumor]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W496</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W490</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1">
<title><![CDATA[18F-FDG PET/CT of Transitional Cell Carcinoma]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to provide a practical
illustrated review of PET/CT in the imaging evaluation of transitional cell
carcinoma.</p>
<p><b>CONCLUSION.</b> Local evaluation of the primary tumor in patients with
transitional cell carcinoma on PET is often limited by the obscuring effect of
excreted FDG, but assessment of metabolic activity may still be possible
through close correlation with CT images. PET/CT may also be helpful in the
detection of disease outside the bladder at nodal or more distant sites and in
the assessment of recurrent disease.</p>
]]></description>
<dc:creator><![CDATA[Patil, V. V., Wang, Z. J., Sollitto, R. A., Chuang, K.-W., Konety, B. R., Hawkins, R. A., Coakley, F. V.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1945</dc:identifier>
<dc:title><![CDATA[18F-FDG PET/CT of Transitional Cell Carcinoma]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W504</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W497</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W505?rss=1">
<title><![CDATA[CT and MRI of Spinal Neuroarthropathy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W505?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to describe the
different stages of spinal neuroarthropathy as assessed by CT and MRI and to
discuss their contribution to the management of affected patients.</p>
<p><b>CONCLUSION.</b> Early-stage findings consisted of inflammatory changes
involving adjacent vertebral endplates and mimicking degenerative disk disease
with inflammation. Subsequently, progression of the lesions led to complete
destruction of the intervertebral joint. Knowledge of the initial features of
spinal neuroarthropathy may allow earlier treatment, which may improve
outcomes.</p>
]]></description>
<dc:creator><![CDATA[Lacout, A., Lebreton, C., Mompoint, D., Mokhtari, S., Vallee, C. A., Carlier, R. Y.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2268</dc:identifier>
<dc:title><![CDATA[CT and MRI of Spinal Neuroarthropathy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W514</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W505</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W515?rss=1">
<title><![CDATA[Bidimensional Measurements in Brain Tumors: Assessment of Interobserver Variability]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W515?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Bidimensional tumor measurements indicating a greater
than 25% increase in tumor size are generally accepted as indicating tumor
progression. We hypothesized that use of digital images and a homogeneous
reader population would have lower interobserver variability than in previous
studies.</p>
<p><b>SUBJECTS AND METHODS.</b> Eight board-certified radiologists measured
tumor diameters in three planes in two consecutive MRI examinations of 22
patients with contrast-enhancing high-grade brain tumors. Products of tumor
measurements were calculated, and determinations were made about tumor
progression (&gt; 25% increase in area). A variance components model was run
on diameter products and the ratios of consecutive maximal diameter products.
The variance components included patient examination effect, reader effect,
and residual effect.</p>
<p><b>RESULTS.</b> Complete agreement was found among readers in 10 cases
(45%), all indicating stable disease. In the other 12 cases, at least one
reader considered progressive disease present. The variance components model
showed variance due to readers was small, indicating only modest bias among
readers. The residual variance component was large (0.038), indicating that
repeated measurements on the same image likely are variable even for the same
reader. This variability in measurement implies that repeated measurements by
the typical reader have an inherent 14% false-positive rate in the diagnosis
of progression of tumors that are stable.</p>
<p><b>CONCLUSION.</b> Our hypothesis was disproved. We found substantial
interreader disagreement and indications that the very nature of the
measurement method produces a high rate of false-positive readings of stable
tumors. These findings should be considered in interpretation of images with
this widely accepted criterion for brain tumor progression.</p>
]]></description>
<dc:creator><![CDATA[Provenzale, J. M., Ison, C., DeLong, D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2615</dc:identifier>
<dc:title><![CDATA[Bidimensional Measurements in Brain Tumors: Assessment of Interobserver Variability]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W522</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W515</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W523?rss=1">
<title><![CDATA[Spectrum of 18F-FDG PET/CT Appearances in Peritoneal Disease]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W523?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to illustrate the spectrum
of appearances of peritoneal diseases on <sup>18</sup>F-FDG PET/CT, show the
usefulness of fused FDG PET/CT as a diagnostic tool for the peritoneum, and
discuss the pitfalls in FDG PET/CT interpretation of peritoneal disease.</p>
<p><b>CONCLUSION.</b> Malignant and benign diseases may have peritoneal
involvement, which can manifest as various imaging patterns on FDG PET/CT.
Awareness of these patterns and of potential interpretation issues is
important to optimize diagnostic accuracy.</p>
]]></description>
<dc:creator><![CDATA[Anthony, M.-P., Khong, P.-L., Zhang, J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2936</dc:identifier>
<dc:title><![CDATA[Spectrum of 18F-FDG PET/CT Appearances in Peritoneal Disease]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W529</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W523</prism:startingPage>
<prism:section>Nuclear Medicine and Molecular Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W530?rss=1">
<title><![CDATA[The Metabolic Spectrum of Venous Thrombotic Disorders Found on PET/CT]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W530?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Thrombotic disorders detected on PET/CT are usually
incidental findings and may change the treatment strategy and patient's
disease prognosis. The purpose of this article is to present the spectrum of
venous thrombotic disorders found on PET/CT.</p>
<p><b>CONCLUSION.</b> The division of thrombotic disorders into metabolically
nonactive and active thrombus may be helpful for differential diagnosis of
underlying diseases causing thrombus formation. IV contrast media
administration during PET/CT makes it possible to visualize the thrombus
itself and helps to distinguish between benign and malignant metabolically
active thrombus.</p>
]]></description>
<dc:creator><![CDATA[Sopov, V., Bernstine, H., Stern, D., Yefremov, N., Sosna, J., Groshar, D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2949</dc:identifier>
<dc:title><![CDATA[The Metabolic Spectrum of Venous Thrombotic Disorders Found on PET/CT]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W539</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W530</prism:startingPage>
<prism:section>Nuclear Medicine and Molecular Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W540?rss=1">
<title><![CDATA[Posterior Periosteal Disruption in Salter-Harris Type II Fractures of the Distal Femur: Evidence for a Hyperextension Mechanism]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W540?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Patterns of periosteal disruption are important factors
in assessing the mechanism of injury of radiologically evident Salter-Harris
(SH) fractures. The purpose of this study is to assess the frequency of
posterior periosteal disruption on MRI in radiographically occult or subtle SH
type II fractures of the distal femur and to evaluate associated soft-tissue
findings that support a hyperextension mechanism of injury.</p>
<p><b>CONCLUSION.</b> We found that all children in our experience with occult
or subtle SH type II fractures of the distal femur have posterior periosteal
disruption and other MRI findings to indicate a hyperextension mechanism of
injury. Direct indicators of fracture may be inconspicuous, and the presence
of posterior periosteal disruption is a clue that should prompt a search for
other features of this serious pediatric injury, which may be followed by limb
shortening or angular deformity.</p>
]]></description>
<dc:creator><![CDATA[Kritsaneepaiboon, S., Shah, R., Murray, M. M., Kleinman, P. K.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2353</dc:identifier>
<dc:title><![CDATA[Posterior Periosteal Disruption in Salter-Harris Type II Fractures of the Distal Femur: Evidence for a Hyperextension Mechanism]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W545</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W540</prism:startingPage>
<prism:section>Pediatric Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W546?rss=1">
<title><![CDATA[Clinical Uses of Time-Resolved Imaging in the Body and Peripheral Vascular System]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W546?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Time-resolved MR angiography (MRA) is a technique
designed for fast vascular imaging. The purpose of this article is to
introduce the multiple potential uses for time-resolved MRA in the body and
peripheral vascular system in the hope that time-resolved MRA will become a
more widely used technique.</p>
<p><b>CONCLUSION.</b> Time-resolved MRA is a useful technique with many
clinical applications.</p>
]]></description>
<dc:creator><![CDATA[Cornfeld, D., Mojibian, H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2826</dc:identifier>
<dc:title><![CDATA[Clinical Uses of Time-Resolved Imaging in the Body and Peripheral Vascular System]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W557</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W546</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W558?rss=1">
<title><![CDATA[Evaluation of Uterine Anomalies: 3D FRFSE Cube Versus Standard 2D FRFSE]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W558?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare a novel MRI
sequence&mdash;3D fast-recovery fast spin-echo (FRFSE) cube&mdash;with a
standard 2D FRFSE sequence for the investigation of uterine anomalies.</p>
<p><b>CONCLUSION.</b> Compared with 2D FRFSE, 3D FRFSE cube provides superior
image quality and improved 3D reconstructions in a shorter acquisition time
and enables excellent visualization of uterine anatomy in any orientation,
regardless of the original scanning plane.</p>
]]></description>
<dc:creator><![CDATA[Agrawal, G., Riherd, J. M., Busse, R. F., Hinshaw, J. L., Sadowski, E. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2716</dc:identifier>
<dc:title><![CDATA[Evaluation of Uterine Anomalies: 3D FRFSE Cube Versus Standard 2D FRFSE]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W562</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W558</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W563?rss=1">
<title><![CDATA[Halfpipe Coaxial Cannula for Self-Contained Vacuum-Assisted Biopsy Systems: Feasibility in a Pig Breast Model]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W563?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to discuss the development
of a dedicated halfpipe coaxial cannula for stereotactic vacuum-assisted
biopsy. We evaluated the system by retrieving 18 copper targets from a pig
breast model in the upright position via vertical and lateral approaches.</p>
<p><b>CONCLUSION.</b> Sampling was successful in 15 of 18 cases. Errors
occurred only in superficial lesions biopsied via the vertical approach. The
halfpipe coaxial cannula shows promise for improving positioning accuracy,
avoiding target dislocation, and obviating repeated needle repositioning.</p>
]]></description>
<dc:creator><![CDATA[Teubner, T., Hafner, M. F., Schimmele, M., Teubner, J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2876</dc:identifier>
<dc:title><![CDATA[Halfpipe Coaxial Cannula for Self-Contained Vacuum-Assisted Biopsy Systems: Feasibility in a Pig Breast Model]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W566</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W563</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/W567?rss=1">
<title><![CDATA[Musculoskeletal MRI, 2nd ed]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/W567?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Garner, H. W.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3252</dc:identifier>
<dc:title><![CDATA[Musculoskeletal MRI, 2nd ed]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W567</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W567</prism:startingPage>
<prism:section>Book Reviews</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/W568?rss=1">
<title><![CDATA[Dialysis Access-Associated Steal Syndrome Presenting as Bidirectional Flow at Duplex Doppler Ultrasound]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/W568?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Yilmaz, C., Ozcan, K., Erkan, N.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2899</dc:identifier>
<dc:title><![CDATA[Dialysis Access-Associated Steal Syndrome Presenting as Bidirectional Flow at Duplex Doppler Ultrasound]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W568</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W568</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/W569?rss=1">
<title><![CDATA[MR Spectroscopy for Differentiation of Recurrent Glioma From Radiation-Induced Changes]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/W569?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Goenka, A. H., Kumar, A., Sharma, R.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3147</dc:identifier>
<dc:title><![CDATA[MR Spectroscopy for Differentiation of Recurrent Glioma From Radiation-Induced Changes]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W570</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W569</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/1471?rss=1">
<title><![CDATA[More New Challenges and Opportunities]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/1471?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Berquist, T. H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3802</dc:identifier>
<dc:title><![CDATA[More New Challenges and Opportunities]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1472</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1471</prism:startingPage>
<prism:section>From the Editor's Notebook</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/1475?rss=1">
<title><![CDATA[Malpractice Issues in Radiology: Res Ipsa Loquitur]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/1475?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Berlin, L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3137</dc:identifier>
<dc:title><![CDATA[Malpractice Issues in Radiology: Res Ipsa Loquitur]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1480</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1475</prism:startingPage>
<prism:section>Medical&amp;ndash;Legal</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/1481?rss=1">
<title><![CDATA[Bad Money Drives Out Good: Forebodings of a Corporatized American Radiology--The 2009 Eugene Caldwell Lecture]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/1481?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hillman, B. J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3144</dc:identifier>
<dc:title><![CDATA[Bad Money Drives Out Good: Forebodings of a Corporatized American Radiology--The 2009 Eugene Caldwell Lecture]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1485</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1481</prism:startingPage>
<prism:section>Special Article</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/1486?rss=1">
<title><![CDATA[Conventional Wisdom: Unconventional Virus]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/1486?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ketai, L. H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3758</dc:identifier>
<dc:title><![CDATA[Conventional Wisdom: Unconventional Virus]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1487</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1486</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1488?rss=1">
<title><![CDATA[Chest Radiographic and CT Findings in Novel Swine-Origin Influenza A (H1N1) Virus (S-OIV) Infection]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1488?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> This article reviews the chest radiographic and CT
findings in patients with presumed/laboratory-confirmed novel swine-origin
influenza A (H1N1) virus (S-OIV) infection.</p>
<p><b>MATERIALS AND METHODS.</b> Of 222 patients with novel S-OIV (H1N1)
infection seen from May 2009 to July 2009, 66 patients (30%) who underwent
chest radiographs formed the study population. Group 1 patients (<I>n</I> =
14) required ICU admission and advanced mechanical ventilation, and group 2
(<I>n</I> = 52) did not. The initial radiographs were evaluated for the
pattern (consolidation, ground-glass, nodules, and reticulation),
distribution, and extent of abnormality. Chest CT scans (<I>n</I> = 15) were
reviewed for the same findings and for pulmonary embolism (PE) when performed
using IV contrast medium.</p>
<p><b>RESULTS.</b> Group 1 patients were predominantly male with a higher mean
age (43.5 years versus 22.1 years in group 2; <I>p</I> &lt; 0.001). The
initial radiograph was abnormal in 28 of 66 (42%) subjects. The predominant
radiographic finding was patchy consolidation (14/28; 50%) most commonly in
the lower (20/28; 71%) and central lung zones (20/28; 71%). All group 1
patients had abnormal initial radiographs; extensive disease involving &ge; 3
lung zones was seen in 93% (13/14) versus 9.6% (5/52) in group 2 (<I>p</I>
&lt; 0.001). No group 2 patients had &gt; 20% overall lung involvement on
initial radiographs compared with 93% of group 1 patients (13/14). PEs were
seen on CT in 5/14 (36%) of group 1 patients.</p>
<p><b>CONCLUSION.</b> Chest radiographs are normal in more than half of
patients with S-OIV (H1N1) and progress to bilateral extensive air-space
disease in severely ill patients, who are at a high risk for PE.</p>
]]></description>
<dc:creator><![CDATA[Agarwal, P. P., Cinti, S., Kazerooni, E. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3599</dc:identifier>
<dc:title><![CDATA[Chest Radiographic and CT Findings in Novel Swine-Origin Influenza A (H1N1) Virus (S-OIV) Infection]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1493</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1488</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1494?rss=1">
<title><![CDATA[Swine-Origin Influenza A (H1N1) Viral Infection: Radiographic and CT Findings]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1494?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to review the chest
radiographic and CT findings in patients with swine-origin influenza A (H1N1)
virus (S-OIV) infection.</p>
<p><b>CONCLUSION.</b> The most common radiographic and CT findings in seven
patients with S-OIV infection are unilateral or bilateral ground-glass
opacities with or without associated focal or multifocal areas of
consolidation. On MDCT, the ground-glass opacities and areas of consolidation
had a predominant peribronchovascular and subpleural distribution, resembling
organizing pneumonia.</p>
]]></description>
<dc:creator><![CDATA[Ajlan, A. M., Quiney, B., Nicolaou, S., Muller, N. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3625</dc:identifier>
<dc:title><![CDATA[Swine-Origin Influenza A (H1N1) Viral Infection: Radiographic and CT Findings]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1499</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1494</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1500?rss=1">
<title><![CDATA[Imaging Findings in a Fatal Case of Pandemic Swine-Origin Influenza A (H1N1)]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1500?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Although most cases of swine-origin influenza A (H1N1)
virus (S-OIV) have been self-limited, fatal cases raise questions about
virulence and radiology's role in early detection. We describe the
radiographic and CT findings in a fatal S-OIV infection.</p>
<p><b>CONCLUSION.</b> Radiography showed peripheral lung opacities. CT
revealed peripheral ground-glass opacities suggesting peribronchial injury.
These imaging findings raised suspicion of S-OIV despite negative H1N1
influenza rapid antigen test results from two nasopharyngeal swabs;
subsequently, those results were proven to be false-negatives by reverse
transcriptase polymerase chain reaction. This case suggests a role for CT in
the early recognition of severe S-OIV.</p>
]]></description>
<dc:creator><![CDATA[Mollura, D. J., Asnis, D. S., Crupi, R. S., Conetta, R., Feigin, D. S., Bray, M., Taubenberger, J. K., Bluemke, D. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3365</dc:identifier>
<dc:title><![CDATA[Imaging Findings in a Fatal Case of Pandemic Swine-Origin Influenza A (H1N1)]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1503</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1500</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1504?rss=1">
<title><![CDATA[Imaging of Thoracic Lymphatic Diseases]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1504?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> This review will focus on radiographic description of
lymphangiomas, lymphangiohemangiomas, pulmonary lymphangiomatosis,
lymphangiectasis, lymphangioleiomyomatosis, lymphatic dysplasia, and traumatic
lymphatic injury.</p>
<p><b>CONCLUSION.</b> Diseases of the thoracic lymphatic system have a wide
variety of unique radiographic manifestations, all of which can be explained
by the underlying pathophysiology and relationship to the normal distribution
of lymphatics in the chest.</p>
]]></description>
<dc:creator><![CDATA[Raman, S. P., Pipavath, S. N. J., Raghu, G., Schmidt, R. A., Godwin, J. D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2532</dc:identifier>
<dc:title><![CDATA[Imaging of Thoracic Lymphatic Diseases]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1513</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1504</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1514?rss=1">
<title><![CDATA[Image Quality of Coronary 320-MDCT in Patients With Atrial Fibrillation: Initial Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1514?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Noninvasive coronary angiography has generally been
contraindicated in patients with atrial fibrillation because of the difficulty
in synchronizing an irregular heartbeat with table gantry movement. The
objective of this study was to evaluate and compare the quality of 320-MDCT
images obtained in patients with atrial fibrillation and in a control group of
patients in sinus rhythm.</p>
<p><b>MATERIALS AND METHODS.</b> Two reviewers were blinded to the patient
groups and evaluated images of 15 coronary artery segments for each patient
using 320-MDCT. The images were printed on glossy paper and scored
subjectively as 1 or 2, meaning of diagnostic quality, or 3, meaning poor
quality.</p>
<p><b>RESULTS.</b> No statistical difference between the groups was noted in
patient age: The mean age of the patients with atrial fibrillation was 67
years (age range, 52&ndash;82 years) and that of the patients in sinus rhythm
was 59 years (36&ndash;86 years) (<I>p</I> = 0.3). Scores of 1 and 2
(diagnostic quality) were assigned to 100% in sinus rhythm and 96% in atrial
fibrillation (<I>p</I> &lt; 0.05). Scores of 3 were seen only in the atrial
fibrillation group (7/175, 4%). Segment 15, the distal circumflex artery, was
the segment that was most frequently assigned a score of 3 (2/7, 28.6%). A
discrepancy in the two reviewers' scores was seen in 25 segments (7%),
requiring joint consensus. The segments that most frequently required
consensus reading were segments 12 and 15. The overall mean image quality
score for all three coronary arteries in atrial fibrillation was 1.25 &plusmn;
0.47 (SD) and 1.08 &plusmn; 0.26 in sinus rhythm (<I>p</I> &lt; 0.001). The
median effective dose was 19.28 and 13.55 mSv in the atrial fibrillation and
sinus rhythm groups, respectively.</p>
<p><b>CONCLUSION.</b> The analysis of our initial experience shows that
imaging in patients with atrial fibrillation is possible using 320-MDCT, with
images of most segments obtained being of diagnostic quality. Segment 15 was
the most difficult to see on 320-MDCT because of the small caliber of the
vessel; poor visualization of that segment mostly occurred in the setting of a
dominant right coronary arterial system.</p>
]]></description>
<dc:creator><![CDATA[Pasricha, S. S., Nandurkar, D., Seneviratne, S. K., Cameron, J. D., Crossett, M., Schneider-Kolsky, M. E., Troupis, J. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2319</dc:identifier>
<dc:title><![CDATA[Image Quality of Coronary 320-MDCT in Patients With Atrial Fibrillation: Initial Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1521</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1514</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1522?rss=1">
<title><![CDATA[Amplatzer Septal Occluder Closure of Atrial Septal Defect: Evaluation of Transthoracic Echocardiography, Cardiac CT, and Transesophageal Echocardiography]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1522?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare transthoracic
echocardiography (TTE), cardiac CT, and transesophageal echocardiography (TEE)
in the evaluation of secundum atrial septal defect (ASD) for closure with an
Amplatzer septal occluder in pediatric patients.</p>
<p><b>SUBJECTS AND METHODS.</b> The cases of 28 children with ASD initially
diagnosed with TTE who were scheduled for cardiac CT for evaluation for
insertion of an Amplatzer septal occluder under TEE guidance were reviewed.
The patients were divided into a group with small ASD (long axis &lt; 1.5 cm)
and a group with large ASD (long axis &ge; 1.5 cm). Measurements of the ASD
obtained at TTE, cardiac CT, and TEE were compared. Kappa statistics were used
to correlate the diagnostic value of cardiac CT assessed by two independent
reviewers.</p>
<p><b>RESULTS.</b> After cardiac CT, six patients were excluded from occluder
implantation; therefore, 22 patients (seven boys, 15 girls; mean age, 4.95
years; range, 2&ndash;11 years) were included in the study. There were no
significant differences in the ages and sexes of the patients in the two
groups, but pulmonary-to-systemic blood flow ratio in the large-ASD group was
significantly greater than that in the small-ASD group (3.54 &plusmn; 1.43 vs
1.89 &plusmn; 0.36; <I>p</I> = 0.001). With respect to long- and short-axis
lengths of the ASD, interatrial septum, and four rims and to detection of rim
deficiency, neither group had a significant difference between cardiac CT
findings at ventricular end-systole and TEE findings. The long axis of the ASD
in the large-ASD group measured at cardiac CT at end-systole and TEE was
significantly longer than the long axis measured at TTE (<I>p</I> = 0.012).
A high diagnostic score with good interobserver correlation ( =
0.674&ndash;0.750) validated the feasibility of cardiac CT in the assessment
of ASD for closure with an Amplatzer septal occluder.</p>
<p><b>CONCLUSION.</b> The long axis of a large ASD can be underestimated at
TTE. Cardiac CT seems comparable with TEE in the assessment of ASD and is
helpful in noninvasive evaluation for Amplatzer septal occluder implantation,
especially for large ASD.</p>
]]></description>
<dc:creator><![CDATA[Ko, S.-F., Liang, C.-D., Yip, H.-K., Huang, C.-C., Ng, S.-H., Huang, C.-F., Chen, M.-C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2854</dc:identifier>
<dc:title><![CDATA[Amplatzer Septal Occluder Closure of Atrial Septal Defect: Evaluation of Transthoracic Echocardiography, Cardiac CT, and Transesophageal Echocardiography]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1529</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1522</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1531?rss=1">
<title><![CDATA[CT Colonography With Decreased Purgation: Balancing Preparation, Performance, and Patient Acceptance]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1531?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Reduction or elimination of catharsis with fecal tagging
enhances the tolerability of CT colonography (CTC) and may increase compliance
with colorectal cancer (CRC) screening recommendations. We systematically
reviewed studies that prospectively evaluated performance and patient
satisfaction with decreased-purgation CTC and with optical colonoscopy.</p>
<p><b>CONCLUSION.</b> The nine studies reviewed showed moderate-to-good
performance for decreased-purgation CTC; however, data are limited, and study
design and data presentation are inconsistent. Further study of
decreased-purgation CTC and standardization of terminology are needed.</p>
]]></description>
<dc:creator><![CDATA[Mahgerefteh, S., Fraifeld, S., Blachar, A., Sosna, J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2342</dc:identifier>
<dc:title><![CDATA[CT Colonography With Decreased Purgation: Balancing Preparation, Performance, and Patient Acceptance]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1539</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1531</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1540?rss=1">
<title><![CDATA[Percutaneous Aspiration and Ethanolamine Oleate Sclerotherapy for Sustained Resolution of Symptomatic Polycystic Liver Disease: An Initial Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1540?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Surgical therapy for symptomatic polycystic liver disease
is effective but has substantial mortality and morbidity. Minimally invasive
options such as percutaneous aspiration with or without ethanol sclerosis have
had disappointing results. The purpose of this study was to evaluate
percutaneous aspiration with ethanolamine oleate sclerosis in the management
of symptomatic polycystic liver disease.</p>
<p><b>SUBJECTS AND METHODS.</b> The study included 13 patients (11 with
polycystic liver disease, two with simple cysts) with 17 cysts. All patients
underwent percutaneous aspiration of the liver cyst under ultrasound guidance
followed by insertion of a 7-French pigtail catheter, instillation of
ethanolamine oleate (10% of cyst volume), and aspiration of the ethanolamine
oleate. The catheter was kept in place for 24 hours of open drainage and then
removed.</p>
<p><b>RESULTS.</b> All but one of the cysts resolved with one instillation.
The one cyst, in a patient with polycystic liver disease, required two
instillations 3 months apart. The mean initial volume of cysts was 589.8 mL,
and the mean reduction in volume was 88.8%. Both the simple cysts resolved
completely. In the cases of polycystic disease, the volume of cysts larger
than 10 cm in diameter was reduced by 92.8%. Cyst resolution was gradual, and
clinically significant cyst reduction was achieved within 1 year of therapy.
None of the patients needed surgery. The median follow-up period was 54 months
(range, 1 week&ndash;95 months). There were no significant adverse effects,
and all patients had relief of symptoms after therapy.</p>
<p><b>CONCLUSION.</b> This initial experience with a single session of
percutaneous aspiration and ethanolamine oleate sclerosis resulted in
sustained resolution of symptomatic polycystic liver disease with minimal
morbidity, avoidance of surgery, and improvement in quality of life.</p>
]]></description>
<dc:creator><![CDATA[Nakaoka, R., Das, K., Kudo, M., Chung, H., Innoue, T.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1681</dc:identifier>
<dc:title><![CDATA[Percutaneous Aspiration and Ethanolamine Oleate Sclerotherapy for Sustained Resolution of Symptomatic Polycystic Liver Disease: An Initial Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1545</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1540</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1546?rss=1">
<title><![CDATA[Radiologist Performance in Differentiating Polypoid Early From Advanced Gastric Cancer Using Specific CT Criteria: Emphasis on Dimpling Sign]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1546?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to retrospectively
determine whether there are specific CT features that can be used to
differentiate polypoid early from advanced gastric cancer and to assess the
performance of radiologists using specific CT findings for
differentiation.</p>
<p><b>MATERIALS AND METHODS.</b> A review of medical records yielded the cases
of 46 patients, 27 with polypoid early gastric cancer and 19 with polypoid
advanced gastric cancer, whose CT scans were available for review. Two
radiologists retrospectively reviewed the CT images for the presence and depth
of dimpling at the tumor base, the presence of vessel invagination at the
dimpling site, thickening of the low-attenuating outer layer, perigastric
infiltration, and transmural full-thickness enhancement of the lesion.
Individual CT findings relevant as predictors were determined with univariate
and multivariate analyses. Individual review of CT scans subsequently was
performed by two other radiologists, who were blinded to tumor stage but aware
of the results of univariate and multivariate analyses. Individual performance
was evaluated with receiver operating characteristic analysis.</p>
<p><b>RESULTS.</b> The presence of severe dimpling greater than 3.5 mm at the
base of the tumor (odds ratio, 31.3) had the highest odds ratio for
differentiating early from advanced gastric cancer, followed by vessel
invagination (odds ratio, 12.3), the presence of dimpling (odds ratio, 9.8),
perigastric infiltration (odds ratio, 5.2), and transmural full-thickness
enhancement (odds ratio, 4.8). Multivariate analysis showed that the presence
of dimpling greater than 3.5 mm was the only independent variable that
differentiated polypoid advanced gastric cancer from polypoid early gastric
cancer (<I>p</I> = 0.001). Subsequent differentiation of advanced from early
gastric cancer with the described CT findings was very good, yielding areas
under the receiver operating characteristic analysis curves of 0.827 and 0.811
for the two observers.</p>
<p><b>CONCLUSION.</b> Greater than 3.5 mm dimpling and other ancillary CT
findings are helpful in differentiating polypoid advanced gastric cancer from
polypoid early gastric cancer and contribute to good individual accuracy for
differentiation.</p>
]]></description>
<dc:creator><![CDATA[Lee, E. S., Kim, S. H., Lee, J. Y., Kim, S. J., Kim, M. A, Lee, J. M., Han, J. K., Choi, B. I.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2308</dc:identifier>
<dc:title><![CDATA[Radiologist Performance in Differentiating Polypoid Early From Advanced Gastric Cancer Using Specific CT Criteria: Emphasis on Dimpling Sign]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1555</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1546</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1556?rss=1">
<title><![CDATA[Value of Diffusion-Weighted MRI for Assessing Liver Fibrosis and Cirrhosis]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1556?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to determine the
usefulness of the apparent diffusion coefficient (ADC) of liver parenchyma for
determining the severity of liver fibrosis.</p>
<p><b>MATERIALS AND METHODS.</b> This study investigated 78 patients who
underwent diffusion-weighted imaging (DWI) with 1.5-T MRI and pathologic
staging of liver fibrosis based on biopsy. DWI was performed with b values of
50 and 400 s/mm<sup>2</sup>. ADCs of liver were measured using 2.0- to
3.0-cm<sup>2</sup> regions of interest in the right and left lobes of the
liver; the mean ADC value was used for analysis. Pathologic METAVIR scores for
liver fibrosis stage were used as a reference standard.</p>
<p><b>RESULTS.</b> The mean ADC values for fibrosis pathologically staged
using the METAVIR classification system as F0 (<I>n</I> = 11), F1
(<I>n</I> = 16), F2 (<I>n</I> = 10), F3 (<I>n</I> = 14), and F4
(<I>n</I> = 27) were 125.9, 105.0, 104.5, 103.2, and 99.1 <FONT FACE="arial,helvetica">x</FONT>
10<sup>-5</sup> s/mm<sup>2</sup>, respectively. The correlation between the
ADC values and the degree of liver fibrosis was moderate (Spearman's test,
 = &ndash;0.36). There was a significant difference in ADC values between
patients with nonfibrotic liver (F0) and those with cirrhotic liver (F4)
(<I>p</I> = 0.008). The best cutoff ADC value to distinguish between these
groups was 118 <FONT FACE="arial,helvetica">x</FONT> 10<sup>-5</sup> s/mm<sup>2</sup>. However, ADC values
were not useful for differentiating viral hepatitis patients with F2 fibrosis
or higher from those with a lower degree of fibrosis (area under the receiver
operating characteristic curve [AUC] = 0.66) or for differentiating low-stage
fibrosis in all patients from high-stage fibrosis in all patients (AUC =
0.54).</p>
<p><b>CONCLUSION.</b> The ADCs in cirrhotic livers are significantly lower
than those in nonfibrotic livers. However, ADC values measured using the
current generation of scanners are not reliable enough to replace liver biopsy
for staging hepatic fibrosis.</p>
]]></description>
<dc:creator><![CDATA[Sandrasegaran, K., Akisik, F. M., Lin, C., Tahir, B., Rajan, J., Saxena, R., Aisen, A. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2436</dc:identifier>
<dc:title><![CDATA[Value of Diffusion-Weighted MRI for Assessing Liver Fibrosis and Cirrhosis]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1560</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1556</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1561?rss=1">
<title><![CDATA[Comparison of Polyp Size and Volume at CT Colonography: Implications for Follow-Up CT Colonography]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1561?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate the reliability
of polyp measurements at CT colonography and the factors that affect the
measurements.</p>
<p><b>MATERIALS AND METHODS.</b> Fifty colonoscopically proven cases of polyps
6 mm in diameter or larger were analyzed by two observers who measured each
polyp in supine and prone views. Manual measurements of 2D volume by summation
of areas, 2D maximum diameter, and 3D maximum diameter and automated
measurements of 3D maximum diameter and volume were recorded for each observer
and were repeated for one of the observers. Intraobserver and interobserver
agreement was calculated. Analysis was performed to determine the measurement
parameter that correlated most with summation-of-areas volume. Supine and
prone measurements as a surrogate for tracking change in polyp size over time
were analyzed to determine the measurement parameter with the least
variation.</p>
<p><b>RESULTS.</b> Maximum diameter measured manually on 3D images had the
highest correlation with summation-of-areas volume. Manual summation-of-areas
volume was found to have the least variation between supine and prone
measurements.</p>
<p><b>CONCLUSION.</b> Linear polyp measurement in the 3D endoluminal view
appears to be the most reliable parameter for use in the decision to excise a
polyp according to current guidelines. In our study, manual calculation of
volume with summation of areas was found to be the most reliable measurement
parameter for observing polyp growth over serial examinations. High
reliability of polyp measurements is essential for adequate assessment of
change in polyp size over serial examinations because many patients with
intermediate-size polyps are expected to choose surveillance.</p>
]]></description>
<dc:creator><![CDATA[Bethea, E., Nwawka, O. K., Dachman, A. H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2618</dc:identifier>
<dc:title><![CDATA[Comparison of Polyp Size and Volume at CT Colonography: Implications for Follow-Up CT Colonography]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1567</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1561</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1568?rss=1">
<title><![CDATA[Contrast Material Administration Protocols for 64-MDCT Angiography: Altering Volume and Rate and Use of a Saline Chaser to Better Match the Imaging Window--Physiologic Phantom Study]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1568?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to evaluate the effect of
varying volumes and rates of contrast material, use of a saline chaser, and
cardiac output on aortic enhancement characteristics in MDCT angiography
(MDCTA) using a physiologic phantom.</p>
<p><b>MATERIALS AND METHODS.</b> Volumes of 75, 100, and 125 mL of iopamidol,
370 mg I/mL, were administered at rates of 4, 6, and 8 mL/s. The effect of a
saline chaser (50 mL of normal saline, 8 mL/s) was evaluated for each volume
and rate combination. Normal, reduced (33% and 50%), and increased (25%)
cardiac outputs were simulated. Peak aortic enhancement and duration of peak
aortic enhancement were recorded. Analysis of variance models were run with
these effects, and the estimated mean levels for the sets of factor
combinations were determined.</p>
<p><b>RESULTS.</b> Lowering the volume of contrast material resulted in
reduced peak enhancement (example, -56.2 HU [<I>p</I> &lt; 0.0001] with 75
vs 125 mL) and reduced duration of 75% peak enhancement (example, -9.0 seconds
[<I>p</I> &lt; 0.0001] with 75 vs 125 mL). Increasing the rate resulted in
increased peak enhancement (example, 104.5 HU [<I>p</I> &lt; 0.0001] with a
rate of 8 vs 4 mL/s) and decreased duration of 75% peak enhancement (example,
-13.0 seconds [<I>p</I> &lt; 0.001]). Use of a saline chaser resulted in
increased peak enhancement, and this increase was inversely proportional to
contrast material volume. Peak enhancement increased when reduced cardiac
output was simulated. Peak enhancement decreased when increased cardiac output
was simulated.</p>
<p><b>CONCLUSION.</b> Reducing contrast material volume from 125 to 75 mL,
increasing the rate to 6 or 8 mL/s, and use of a saline chaser result in an
aortic enhancement profile that better matches the approximately 5-second
imaging window possible with 64-MDCTA of the abdomen and pelvis. Even smaller
volumes of contrast material may be adequate in patients with reduced cardiac
output.</p>
]]></description>
<dc:creator><![CDATA[Coursey, C. A., Nelson, R. C., Weber, P. W., Howle, L. E., Nichols, E. B., Marin, D., DeLong, D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2670</dc:identifier>
<dc:title><![CDATA[Contrast Material Administration Protocols for 64-MDCT Angiography: Altering Volume and Rate and Use of a Saline Chaser to Better Match the Imaging Window--Physiologic Phantom Study]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1575</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1568</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1576?rss=1">
<title><![CDATA[Duodenal Switch Gastric Bypass Surgery for Morbid Obesity: Imaging of Postsurgical Anatomy and Postoperative Gastrointestinal Complications]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1576?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to evaluate the normal
postsurgical findings and appearance of gastrointestinal tract complications
in patients who have undergone biliopancreatic diversion with duodenal switch
bariatric surgery. We performed a 4-year retrospective review of 218 patients
who underwent duodenal switch surgery.</p>
<p><b>CONCLUSION.</b> The most common complications of duodenal switch surgery
were bowel obstruction, followed by ventral hernias and anastomotic leaks.
Only 2% of cases required repeat surgery for management.</p>
]]></description>
<dc:creator><![CDATA[Mitchell, M. T., Carabetta, J. M., Shah, R. N., O'Riordan, M. A., Gasparaitis, A. E., Alverdy, J. C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1941</dc:identifier>
<dc:title><![CDATA[Duodenal Switch Gastric Bypass Surgery for Morbid Obesity: Imaging of Postsurgical Anatomy and Postoperative Gastrointestinal Complications]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1580</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1576</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1">
<title><![CDATA[MRI in the Detection of Prostate Cancer: Combined Apparent Diffusion Coefficient, Metabolite Ratio, and Vascular Parameters]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare apparent
diffusion coefficients, metabolic ratios, and vascularity values within
histologically defined prostate tumors with those in nontumor tissue to
determine which functional parameter or combination of parameters is best for
differentiating tumor from nontumor tissue.</p>
<p><b>SUBJECTS AND METHODS.</b> Twenty patients due for prostatectomy
underwent endorectal MRI at 1.5 T. Transverse T2-weighted, diffusion-weighted,
2D chemical shift, and dynamic contrast-enhanced images were acquired. After
prostatectomy, the gland was sectioned transversely. Fresh slices and stained
whole-mount sections with histologically defined tumor outlines were
photographed. The tumor outlines were mapped onto images, and the apparent
diffusion coefficient (ADC), choline-to-citrate (Cho/cit) ratio, and
vascularity of the histologically defined tumor, normal peripheral zone, and
central gland were quantitatively measured. Area under the receiver operating
characteristics (ROC) curve (A<I><SUB>z</SUB></I>) was used to determine the
sensitivity and specificity of parameter combinations in cancer detection.</p>
<p><b>RESULTS.</b> In tumor regions larger than 1 cm<sup>2</sup>, the Cho/cit
ratio was higher in tumor than in nontumor tissue (<I>p</I> &lt; 0.001), in
the peripheral zone alone (<I>p</I> = 0.007), and in the central gland alone
(<I>p</I> = 0.005). ADC was lower and tumor vascularity greater in tumor
than in nontumor tissue (ADC, <I>p</I> = 0.003; initial area under the
gadolinium plasma concentration&ndash;time curve [initial gadolinium AUC],
<I>p</I> = 0.012; forward rate constant [K<sup>trans</sup>], <I>p</I> =
0.011; return rate constant [k<SUB>ep</SUB>], <I>p</I> = 0.036). No single
parameter had a significantly greater A<SUB><I>z</I></SUB> (ADC, 0.71;
Cho/cit ratio, 0.79; initial gadolinium AUC, 0.60; K<sup>trans</sup>, 0.62;
k<SUB>ep</SUB>, 0.65). Pairs of parameters, however, did increase
A<I><SUB>z</SUB></I>: ADC and initial gadolinium AUC (A<I><SUB>z</SUB></I>
= 0.94) versus ADC (<I>p</I> = 0.001) and initial gadolinium AUC (<I>p</I>
&lt; 0.001); ADC and Cho/cit ratio (A<SUB><I>z</I></SUB> = 0.94) versus ADC
(<I>p</I> = 0.001) and Cho/cit ratio (not significant); and Cho/cit ratio
and initial gadolinium AUC (A<I><SUB>z</SUB></I> = 0.88) versus Cho/cit
ratio (not significant) and initial gadolinium AUC (<I>p</I> &lt; 0.001).
All three functional techniques together had an A<I><SUB>z</SUB></I> of
0.95, showing no further improvement.</p>
<p><b>CONCLUSION.</b> The combination of two functional parameters is
associated with significant improvement in prostate cancer detection over use
of any parameter alone. Use of a third parameter does not increase the rate of
detection.</p>
]]></description>
<dc:creator><![CDATA[Riches, S. F., Payne, G. S., Morgan, V. A., Sandhu, S., Fisher, C., Germuska, M., Collins, D. J., Thompson, A., deSouza, N. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2540</dc:identifier>
<dc:title><![CDATA[MRI in the Detection of Prostate Cancer: Combined Apparent Diffusion Coefficient, Metabolite Ratio, and Vascular Parameters]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1591</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1583</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1593?rss=1">
<title><![CDATA[From Herding Cats Toward Best Practices: Standardizing the Radiologic Work Process]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1593?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Considerable variation in radiologic procedures,
protocols, policies, and workflows exists across the nation, sometimes even
within departments. This lack of standardization fosters idiosyncratic
behavior and outcomes, undermining the effort to implement best practices
across institutions. The purpose of this article is to discuss the need for
rapidly implementing recognized standards and best practices when they
exist.</p>
<p><b>CONCLUSION.</b> The use of information systems to monitor a wide variety
of quality metrics offers managers the opportunity to standardize radiology
and departmental practices, with the goal of transforming these practices into
those that are more efficient and cost-effective and of higher quality.</p>
]]></description>
<dc:creator><![CDATA[Boland, G. W. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2885</dc:identifier>
<dc:title><![CDATA[From Herding Cats Toward Best Practices: Standardizing the Radiologic Work Process]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1595</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1593</prism:startingPage>
<prism:section>Health Care Policy and Quality</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1596?rss=1">
<title><![CDATA[Influence of Verification Bias on the Assessment of MRI in the Diagnosis of Meniscal Tear]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1596?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Previous studies of the sensitivity and specificity of
MRI in the diagnosis of meniscal tear have not included correction for
verification bias. The purpose of this study was to investigate the extent to
which verification bias affected assessment of the utility of MRI in the
diagnosis of meniscal tear.</p>
<p><b>MATERIALS AND METHODS.</b> The patients included in the study were
outpatients who from April 2006 through July 2008 consecutively visited a
single institution for MRI of the meniscus for evaluation of knee pain. For
patients who underwent arthroscopy in addition to MRI, the sensitivity and
specificity of MRI were calculated. Global sensitivity analysis of data on
patients who did not undergo arthroscopy was performed to estimate the
influence of verification bias. Global sensitivity analysis is a method for
graphically determining whether a particular pair of sensitivity and
specificity estimates is compatible with observed data.</p>
<p><b>RESULTS.</b> Eighty-two patients (23%) underwent arthroscopic
verification. The sensitivity and specificity of MRI were 85% and 31%. When
the possibility of meniscal tears in patients who did not undergo arthroscopy
was subjected to global sensitivity analysis, the sensitivity of MRI ranged
from 29% to 95% and the specificity ranged from 3% to 92%. All combinations of
sensitivity and specificity produced a butterfly-shaped curve, but the base
case was not inside the curve.</p>
<p><b>CONCLUSION.</b> Verification bias greatly affected assessment of the
utility of MRI in the diagnosis of meniscal tear. Sensitivity and specificity
from previous studies may be incompatible with our data owing to verification
bias.</p>
]]></description>
<dc:creator><![CDATA[Nishikawa, H., Imanaka, Y., Sekimoto, M., Hayashida, K., Ikai, H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2223</dc:identifier>
<dc:title><![CDATA[Influence of Verification Bias on the Assessment of MRI in the Diagnosis of Meniscal Tear]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1602</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1596</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1603?rss=1">
<title><![CDATA[Cysts Within and Adjacent to the Lesser Tuberosity and Their Association With Rotator Cuff Abnormalities]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1603?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to determine the incidence
of cysts in and adjacent to the lesser tuberosity and their association with
rotator cuff abnormalities and subcoracoid impingement.</p>
<p><b>MATERIALS AND METHODS.</b> A retrospective review of 1,000 consecutive
MRI examinations of the shoulder was performed by consensus of two
radiologists. Cysts were grouped by location into one of two groups: those
within the lesser tuberosity and those adjacent to the lesser tuberosity. The
rotator cuff was defined as intact, partial tear or tendinosis, or
full-thickness tear. The shortest distance from the coracoid to the humeral
head was measured on axial images.</p>
<p><b>RESULTS.</b> Forty-eight patients (26 women, 22 men; age range,
35&ndash;79 years; mean age, 61 years) had cysts adjacent to or within the
lesser tuberosity. Thirty-two patients (67%) had cysts just superior to the
tuberosity and 16 (33%) had cysts in the lesser tuberosity, resulting in an
incidence of 3.2% and 1.6%, respectively. All 16 patients (100%) with lesser
tuberosity cysts had subscapularis and supraspinatus tendon abnormalities
including 11 (69%) full-thickness supraspinatus tears. Patients with cysts
superior to the tuberosity had 20 (63%, <I>p</I> = 0.004) abnormal
subscapularis tendons and 28 (88%) abnormal supraspinatus tendons, including
six (19%) full-thickness tears (<I>p</I> = 0.002). The coracohumeral
distance was noted to be less than 10 mm in 10 patients (63%) with lesser
tuberosity cysts as compared with 10 patients (31%, <I>p</I> = 0.06) with
cysts superior to the tuberosity.</p>
<p><b>CONCLUSION.</b> Cysts located within the lesser tuberosity are rare and
are indicative of subscapularis and supraspinatus tendon abnormalities.</p>
]]></description>
<dc:creator><![CDATA[Wissman, R. D., Kapur, S., Akers, J., Crimmins, J., Ying, J., Laor, T.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2377</dc:identifier>
<dc:title><![CDATA[Cysts Within and Adjacent to the Lesser Tuberosity and Their Association With Rotator Cuff Abnormalities]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1606</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1603</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1607?rss=1">
<title><![CDATA[MRI of Soft-Tissue Tumors: Fast STIR Sequence as Substitute for T1-Weighted Fat-Suppressed Contrast-Enhanced Spin-Echo Sequence]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1607?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to assess the value of the
fast STIR sequence in comparison with the T1-weighted fat-suppressed
contrast-enhanced sequence in the evaluation of soft-tissue tumors.</p>
<p><b>MATERIALS AND METHODS.</b> Sixty-seven soft-tissue tumors imaged with
both STIR and T1-weighted fat-suppressed contrast-enhanced sequences were
evaluated. The signal-to-noise and contrast-to-noise ratios of the tumors in
comparison with normal muscle, bone marrow, and fat were measured. Subjective
image contrast between soft-tissue tumors and the nearest normal tissue was
evaluated by two observers. The observers classified the soft-tissue tumors as
benign or malignant using a 5-point scale, and sensitivity, specificity, and
accuracy were calculated. The results of the two readings were assessed with
receiver operating characteristic analysis.</p>
<p><b>RESULTS.</b> The contrast-to-noise ratios of all tumors in comparison
with muscle (<I>p</I> &lt; 0.01), bone marrow (<I>p</I> &lt; 0.05), and
fat (<I>p</I> &lt; 0.05) were significantly higher on the fast STIR images
than on the T1-weighted fat-suppressed contrast-enhanced images. Both
observers' mean ratings of benign, malignant, and all tumors in comparison
with muscle on fast STIR images were significantly higher than those on
T1-weighted fat-suppressed contrast-enhanced images. For both observers, the
mean sensitivity, specificity, accuracy, and area under the receiver operating
characteristic curve in evaluation of the fast STIR images did not differ
significantly from those in evaluation of the T1-weighted fat-suppressed
contrast-enhanced images.</p>
<p><b>CONCLUSION.</b> The fast STIR sequence is excellent for evaluation of
soft-tissue tumors, and contrast-enhancement is not always needed.</p>
]]></description>
<dc:creator><![CDATA[Tokuda, O., Harada, Y., Matsunaga, N.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2675</dc:identifier>
<dc:title><![CDATA[MRI of Soft-Tissue Tumors: Fast STIR Sequence as Substitute for T1-Weighted Fat-Suppressed Contrast-Enhanced Spin-Echo Sequence]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1614</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1607</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1615?rss=1">
<title><![CDATA[Sonography of the Lateral Ulnar Collateral Ligament of the Elbow: Study of Cadavers and Healthy Volunteers]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1615?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to assess the utility of
high-resolution sonography in identification and characterization of the size
and echogenicity of the lateral ulnar collateral ligament of the elbow in
cadavers and healthy volunteers.</p>
<p><b>SUBJECTS AND METHODS.</b> The lateral ulnar collateral ligaments of four
cadaveric elbows were imaged with a high-resolution linear-array ultrasound
transducer. On localization, the ligaments were injected with 0.1% methylene
blue under sonographic guidance. For confirmation of identification of the
ligaments, the elbows were immediately dissected to reveal the exact location
of the stain. The ligaments of both elbows of 35 healthy adult volunteers were
imaged.</p>
<p><b>RESULTS.</b> Surgical dissection confirmed injection of methylene blue
into all four cadaveric ligaments. The lateral ulnar collateral ligament was
identified bilaterally over the radial head in all 35 volunteers. The mean
thickness of the ligament at this point was 1.2 mm in women and men. The
proximal attachment of the ligament to the humerus was well visualized
bilaterally in 94.3% of volunteers. The mean thickness at this point was 1.7
mm in women and 1.6 mm in men. The distal attachment on the ulna was well
visualized in 90% of elbows. The ligament was hyperechoic in relation to
muscle in all volunteers. Differences in ligament measurements with regard to
sex and hand dominance were not significant. Ligament thickness correlated
weakly with volunteer weight, height, body mass index, and age.</p>
<p><b>CONCLUSION.</b> High-resolution ultrasound imaging is accurate for
identification and measurement of normal lateral ulnar collateral ligaments.
Therefore, ultrasound may prove valuable in assessment of abnormal lateral
ulnar collateral ligaments.</p>
]]></description>
<dc:creator><![CDATA[Stewart, B., Harish, S., Oomen, G., Wainman, B., Popowich, T., Moro, J. K.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2812</dc:identifier>
<dc:title><![CDATA[Sonography of the Lateral Ulnar Collateral Ligament of the Elbow: Study of Cadavers and Healthy Volunteers]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1619</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1615</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1621?rss=1">
<title><![CDATA[Radiation Dose and Excess Risk of Cancer in Children Undergoing Neuroangiography]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1621?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The primary goal of this study was to determine the
radiation dose received during diagnostic and interventional neuroangiographic
procedures in a group of pediatric patients. A second goal was to approximate
the total average radiation dose from all angiographic and CT studies that
pediatric patients underwent during the study period and to estimate the
increased risk of cancer incidence in this patient group.</p>
<p><b>MATERIALS AND METHODS.</b> The study subjects were pediatric patients
who had undergone one or more neuroangiographic procedures at Harborview
Medical Center between December 1, 2004, and April 30, 2008. Recorded
radiation doses were converted to entrance skin dose (ESD) and effective dose
(ED) to indicate deterministic and stochastic damage, respectively. The
Biologic Effects of Ionizing Radiation (BEIR) VII, phase 2, report was used to
estimate the expected increased risk of cancer in the study population.</p>
<p><b>RESULTS.</b> For diagnostic and therapeutic procedures, a mean ED of
10.4 and 34.0 mSv per procedure was calculated, respectively. The ESD values
proved too low to cause deterministic harm. The estimated number of excess
cases of malignancy projected from the total average radiation exposure was
890.6 per 100,000 exposed male children and 1,222.5 per 100,000 exposed
females, an overall increase of approximately 1% to the lifetime attributable
risk of cancer.</p>
<p><b>CONCLUSION.</b> Although both angiography and CT have revolutionized the
practice of medicine and confer benefits to patients, it is important that we
continue to investigate the possible adverse effects of these technologies.
Protocols that minimize radiation dose without compromising a study should be
implemented.</p>
]]></description>
<dc:creator><![CDATA[Raelson, C. A., Kanal, K. M., Vavilala, M. S., Rivara, F. P., Kim, L. J., Stewart, B. K., Cohen, W. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2352</dc:identifier>
<dc:title><![CDATA[Radiation Dose and Excess Risk of Cancer in Children Undergoing Neuroangiography]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1628</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1621</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1629?rss=1">
<title><![CDATA[Reperfusion Phenomenon Masking Acute and Subacute Infarcts at Dynamic Perfusion CT: Confirmation by Fusion of CT and Diffusion-Weighted MR Images]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1629?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate cerebral blood
flow, cerebral blood volume, mean transit time, time to peak, and delay in a
selected sample of patients with visually normal or increased cerebral blood
volume to facilitate detection of a postischemic CT perfusion
hyperperfusion&ndash;reperfusion phenomenon that may mask subacute and acute
infarcts.</p>
<p><b>MATERIALS AND METHODS.</b> Ten patients were included who had visually
normal or elevated cerebral blood volume in infarcts larger than 1.5 cm
confirmed on diffusion-weighted MR images within 48 hours of perfusion CT. The
cases were selected from 371 perfusion CT studies of stroke patients (99
associated with positive diffusion-weighted imaging findings) reviewed over
2.5 years on a 64-MDCT scanner. The perfusion CT images were fused to the
diffusion-weighted images for measurement of cerebral blood volume, cerebral
blood flow, mean transit time, time to peak, and delay in each infarct versus
the contralateral hemisphere. Two neuroradiologists reviewed the images in
consensus.</p>
<p><b>RESULTS.</b> The mean time between symptom onset and perfusion CT was
3.9 days. Infarcts were in the middle cerebral artery (<I>n</I> = 7) and
posterior cerebral artery (<I>n</I> = 3) distributions. Significant
differences versus the contralateral finding were found in cerebral blood
volume (<I>p</I> = 0.016; mean increase, 30.0%), mean transit time
(<I>p</I> = 0.007; mean increase, 38.1%), time to peak (<I>p</I> = 0.005;
mean increase, 17.7%), and delay (<I>p</I> = 0.030; mean increase, 124.9%).
The difference in cerebral blood flow (<I>p</I> = 0.785; mean increase,
1.8%) was not statistically significant. Infarcts became enhanced on the
dynamic perfusion CT images of eight of 10 patients and on the
contrast-enhanced T1-weighted MR images of six of nine patients.</p>
<p><b>CONCLUSION.</b> Visual inspection of cerebral blood volume and cerebral
blood flow maps alone is insufficient in the evaluation of infarcts. Mean
transit time, time to peak, and delay maps also should be reviewed with
dynamic source images to prevent misinterpretation of findings as
false-negative. This phenomenon is unlikely to occur hyperacutely (&lt; 8
hours after onset).</p>
]]></description>
<dc:creator><![CDATA[Nagar, V. A., McKinney, A. M., Karagulle, A. T., Truwit, C. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2664</dc:identifier>
<dc:title><![CDATA[Reperfusion Phenomenon Masking Acute and Subacute Infarcts at Dynamic Perfusion CT: Confirmation by Fusion of CT and Diffusion-Weighted MR Images]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1638</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1629</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1640?rss=1">
<title><![CDATA[Respiratory Gating Enhances Imaging of Pulmonary Nodules and Measurement of Tracer Uptake in FDG PET/CT]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1640?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The aim of this study was to evaluate prospectively the
effects of respiratory gating during FDG PET/CT on the determination of lesion
size and the measurement of tracer uptake in patients with pulmonary nodules
in a clinical setting.</p>
<p><b>SUBJECTS AND METHODS.</b> Eighteen patients with known pulmonary nodules
(nine women, nine men; mean age, 61.4 years) underwent conventional FDG PET/CT
and respiratory-gated PET acquisitions during their scheduled staging
examinations. Maximum, minimum, and average standardized uptake values (SUVs)
and lesion size and volume were determined with and without respiratory
gating. The results were then compared using the two-tailed Student's
<I>t</I> test and the nonparametric Wilcoxon's test to assess the effects of
respiratory gating on PET acquisitions.</p>
<p><b>RESULTS.</b> Respiratory gating reduced the measured area of lung
lesions by 15.5%, the axial dimension by 10.3%, and the volume by 44.5%
(<I>p</I> = 0.014, <I>p</I> = 0.007, and <I>p</I> = 0.025,
respectively). The lesion volumes in gated studies were closer to those
assessed by standard CT (difference decreased by 126.6%, <I>p</I> = 0.025).
Respiratory gating increased the measured maximum SUV by 22.4% and average SUV
by 13.3% (<I>p</I> &lt; 0.001 and <I>p</I> = 0.002).</p>
<p><b>CONCLUSION.</b> Our findings suggest that the use of PET respiratory
gating in PET/CT results in lesion volumes closer to those assessed by CT and
improved measurements of tracer uptake for lesions in the lungs.</p>
]]></description>
<dc:creator><![CDATA[Werner, M. K., Parker, J. A., Kolodny, G. M., English, J. R., Palmer, M. R.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2516</dc:identifier>
<dc:title><![CDATA[Respiratory Gating Enhances Imaging of Pulmonary Nodules and Measurement of Tracer Uptake in FDG PET/CT]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1645</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1640</prism:startingPage>
<prism:section>Nuclear Medicine and Molecular Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1648?rss=1">
<title><![CDATA[Comparison of Ultrasound and CT in the Evaluation of Pneumonia Complicated by Parapneumonic Effusion in Children]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1648?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to compare chest ultrasound
and chest CT in children with complicated pneumonia and parapneumonic
effusion.</p>
<p><b>MATERIALS AND METHODS.</b> We retrospectively compared chest ultrasound
and chest CT in 19 children (nine girls and 10 boys; age range, 8
months&ndash;17 years) admitted with complicated pneumonia and parapneumonic
effusion between December 2006 and January 2009. Images were evaluated for
effusion, loculation, fibrin strands, parenchymal consolidation, necrosis, and
abscess. In the subset of patients who underwent surgical management, imaging
findings were correlated with operative findings.</p>
<p><b>RESULTS.</b> Eighteen of 19 patients had an effusion on both chest
ultrasound and chest CT. The findings of effusion loculation as well as
parenchymal consolidation and necrosis or abscess were similar between the two
techniques. Chest ultrasound was better able to visualize fibrin strands
within the effusions. Of the 14 patients who underwent video-assisted
thoracoscopy, five had surgically proven parenchymal abscess or necrosis.
Preoperatively, chest ultrasound was able to show parenchymal abscess or
necrosis in four patients, whereas chest CT was able to show parenchymal
abscess or necrosis in three.</p>
<p><b>CONCLUSION.</b> In our series, chest ultrasound and chest CT were
similar in their ability to detect loculated effusion and lung necrosis or
abscess resulting from complicated pneumonia. Chest CT did not provide any
additional clinically useful information that was not also seen on chest
ultrasound. We suggest that the imaging workup of complicated pediatric
pneumonia include chest radiography and chest ultrasound, reserving chest CT
for cases in which the chest ultrasound is technically limited or discrepant
with the clinical findings.</p>
]]></description>
<dc:creator><![CDATA[Kurian, J., Levin, T. L., Han, B. K., Taragin, B. H., Weinstein, S.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2791</dc:identifier>
<dc:title><![CDATA[Comparison of Ultrasound and CT in the Evaluation of Pneumonia Complicated by Parapneumonic Effusion in Children]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1654</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1648</prism:startingPage>
<prism:section>Pediatric Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1656?rss=1">
<title><![CDATA[Coagulation Concepts Update]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1656?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Since the previous comprehensive radiology review on
coagulation concepts that was done in 1990, many studies have been published
in the medical and surgical literature that can guide the approach of a
radiology practice. The purpose of this article is to provide an analysis of
these works, updating the radiologist on proper use and interpretation of
coagulation assessment tools, medications that modify the hemostatic system,
and the use of transfusions prior to interventions.</p>
<p><b>CONCLUSION.</b> The basic tools for coagulation assessment have not
changed; however, results from subspecialty research have suggested ways in
which the use of these tools can be modified and streamlined to safely reduce
time and expense for the patient and the health care system.</p>
]]></description>
<dc:creator><![CDATA[O'Connor, S. D., Taylor, A. J., Williams, E. C., Winter, T. C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2191</dc:identifier>
<dc:title><![CDATA[Coagulation Concepts Update]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1664</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1656</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1665?rss=1">
<title><![CDATA[Triple-Drug Transcatheter Arterial Chemoembolization in Unresectable Hepatocellular Carcinoma: Assessment of Survival in 124 Consecutive Patients]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1665?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to describe survival
outcome in 124 patients with unresectable hepatocellular carcinoma treated
with triple-drug transcatheter arterial chemoembolization (TACE) using
doxorubicin, cisplatin, and mitomycin C using a standardized regimen.</p>
<p><b>MATERIALS AND METHODS.</b> One hundred twenty-four patients underwent
TACE using a standardized triple-drug regimen. Embolization was performed
using subselective coaxial embolization technique. Fifty-six patients (group
1) received triple-drug TACE in conjunction with a nonpermanent embolic agent,
microfibrillar collagen (Avitene), and 68 patients (group 2) had triple-drug
TACE with a permanent embolic agent, Embosphere Microspheres.</p>
<p><b>RESULTS.</b> Twenty-eight patients underwent liver transplantation after
TACE, and survival in these patients was significantly longer than those who
did not receive a transplant (<I>p</I> &le; 0.001). The mean survival for
the no-transplant group (<I>n</I> = 96) was longer in patients with
Child-Pugh class A cirrhosis than in those with Child-Pugh class B cirrhosis
(30.3 &plusmn; 2.92 [standard error] vs 11.6 &plusmn; 2.84 months,
respectively; <I>p</I> &lt; 0.001), in those with Okuda stage I versus stage
II disease (31.4 &plusmn; 3.03 vs 17.4 &plusmn; 3.16 months; <I>p</I> =
0.002), and in those with a pre-TACE bilirubin level of less than 2.5 mg/dL
(42.75 &micro;mol/L; 28.3 &plusmn; 2.75 vs 13.2 &plusmn; 3.83 months; <I>p</I>
= 0.007). Improved survival was seen in the no-transplant patients receiving
TACE with the permanent embolic agent (group 2) than in those receiving TACE
with the nonpermanent agent (group 1) out to 30 months (<I>p</I> = 0.002).
Complications occurred in 16 patients (12.9%). The 30-day mortality was
2.4%.</p>
<p><b>CONCLUSION.</b> Patients with hepatocellular carcinoma who underwent
triple-drug TACE followed by liver transplantation showed the longest
survival. Patients who did not receive a transplant and were treated with
triple-drug TACE with a permanent embolic agent showed longer survival to 30
months after TACE than those receiving a nonpermanent embolic agent.</p>
]]></description>
<dc:creator><![CDATA[Gomes, A. S., Rosove, M. H., Rosen, P. J., Amado, R. G., Sayre, J. W., Monteleone, P. A., Busuttil, R. W.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1806</dc:identifier>
<dc:title><![CDATA[Triple-Drug Transcatheter Arterial Chemoembolization in Unresectable Hepatocellular Carcinoma: Assessment of Survival in 124 Consecutive Patients]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1671</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1665</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1672?rss=1">
<title><![CDATA[Long-Term Results of Angioplasty and Stent Placement for Treatment of Central Venous Obstruction in 126 Hemodialysis Patients: A 10-Year Single-Center Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1672?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to report and compare
long-term results of percutaneous transluminal angioplasty and stenting of
central venous obstruction in hemodialysis patients.</p>
<p><b>MATERIALS AND METHODS.</b> Hemodialysis patients who underwent
successful endovascular treatment of central venous obstruction were
retrospectively evaluated. Stenotic lesions greater than 50% or inducing
extremity swelling were subject to treatment. The primary treatment was
angioplasty, and stent placement was accomplished in angioplasty-resistant
obstructions. Angioplasty was the primary treatment of recurrence after stent
placement. Additional stenting was reserved for angioplasty-resistant
recurrences.</p>
<p><b>RESULTS.</b> One hundred forty-seven veins in 126 patients (63 males, 63
females) between 15 and 82 years old primarily underwent 101 angioplasties and
46 stent placements. The mean follow-up was 22.1 &plusmn; 16.3 (SD) months.
The average number of interventions per vein in the stent group (2.7 &plusmn;
2.4 interventions) was significantly higher than that in the angioplasty group
(1.5 &plusmn; 1.0 interventions). Primary patency was significantly higher in
the angioplasty group (mean, 24.5 &plusmn; 1.7 months) than that in the stent
group (mean, 13.4 &plusmn; 2.0 months). Assisted primary patency of the
angioplasty group (mean, 31.4 &plusmn; 2.0 months) and that of the stent group
(mean, 31.0 &plusmn; 4.7 months) were equivalent. The overall mean primary
patency was 21.1 &plusmn; 1.4 months, and the overall mean assisted primary
patency was 31.7 &plusmn; 2.5 months. There were no significant differences in
patency rates with regard to patient sex, the type of stent used, the vein or
veins treated, or the type of lesions.</p>
<p><b>CONCLUSION.</b> Endovascular treatment of central venous obstruction is
a safe and effective procedure in hemodialysis patients. Stenting has a
significantly lower primary patency rate than angioplasty but adds to the
longevity of vein patency in angioplasty-resistant lesions; therefore, stent
placement should be considered in angioplasty-resistant lesions.</p>
]]></description>
<dc:creator><![CDATA[Ozyer, U., Harman, A., Yildirim, E., Aytekin, C., Karakayali, F., Boyvat, F.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2654</dc:identifier>
<dc:title><![CDATA[Long-Term Results of Angioplasty and Stent Placement for Treatment of Central Venous Obstruction in 126 Hemodialysis Patients: A 10-Year Single-Center Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1679</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1672</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1680?rss=1">
<title><![CDATA[Radiation Dose of Interventional Radiology System Using a Flat-Panel Detector]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1680?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Currently, cardiac interventional radiology equipment has
tended toward using flat-panel detectors (FPDs) instead of image intensifiers
(IIs) because FPDs offer better imaging performance. However, the radiation
dose from an FPD in cardiac interventional radiology is not clear. The purpose
of our study was to measure the radiation doses during cineangiography and
fluoroscopy of many cardiac radiology systems that use FPDs or IIs, in
clinical settings.</p>
<p><b>MATERIALS AND METHODS.</b> This study examined 20 radiology systems in
15 cardiac catheterization laboratories (11 used FPD and nine used II). The
entrance surface doses with digital cineangiography and fluoroscopy were
compared for the 20 systems using acrylic plates (20-cm thick) and a skin dose
monitor.</p>
<p><b>RESULTS.</b> For fluoroscopy, the average entrance surface doses of the
20-cm-thick acrylic plates were identical for FPD (average &plusmn; SD, 16.63
&plusmn; 7.89 mGy/min; range, 5.7&ndash;26.4 mGy/min; maximum/minimum, 4.63)
and II (17.81 &plusmn; 12.52 mGy/min; range, 6.5&ndash;42.2 mGy/min;
maximum/minimum, 6.49) (<I>p</I> = 0.799). For digital cineangiography, the
average entrance surface dose of the 20-cm-thick acrylic plate was slightly
lower with FPD (29.68 &plusmn; 16.40 mGy/10 s; range, 8.9&ndash;58.5 mGy/10 s;
maximum/minimum, 6.57) than with II (38.50 &plusmn; 33.71 mGy/10 s; range,
15.2&ndash;117.1 mGy/10 s; maximum/minimum, 7.70), although the difference was
not significant (<I>p</I> = 0.487).</p>
<p><b>CONCLUSION.</b> We found that the average entrance doses of
cineangiography and fluoroscopy in FPD systems were not significantly
different from those in II systems. Hence, FPDs did not inherently reduce the
radiation dose, although FPDs possess good detective quantum efficiency.
Therefore, to reduce the radiation dose of cardiac interventional radiology
systems, even FPD systems, practical measures are necessary.</p>
]]></description>
<dc:creator><![CDATA[Chida, K., Inaba, Y., Saito, H., Ishibashi, T., Takahashi, S., Kohzuki, M., Zuguchi, M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2747</dc:identifier>
<dc:title><![CDATA[Radiation Dose of Interventional Radiology System Using a Flat-Panel Detector]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1685</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1680</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1686?rss=1">
<title><![CDATA[Percutaneous CT-Guided Radiofrequency Ablation of Renal Cell Carcinoma: Efficacy of Organ Displacement by Injection of 5% Dextrose in Water Into the Retroperitoneum]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1686?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this study was to evaluate the
effectiveness of CT-guided injection of 5% dextrose in water solution (D5W)
into the retroperitoneum to displace organs adjacent to renal cell
carcinoma.</p>
<p><b>MATERIALS AND METHODS.</b> An interventional radiology database was
searched to identify the cases of patients who underwent CT-guided
percutaneous radiofrequency ablation of biopsy-proven renal cell carcinoma in
which D5W was injected into the retroperitoneal space to displace structures
away from the targeted renal tumor. The number of organs displaced and the
distance between the renal tumor and adjacent organs before and after
displacement with D5W were assessed.</p>
<p><b>RESULTS.</b> The cases of 135 patients with 139 biopsy-proven renal cell
carcinomas who underwent 154 percutaneous CT-guided radiofrequency ablation
procedures were found in the search. Thirty-one patients with 33 renal cell
carcinomas underwent 36 ablation procedures after injection of D5W into the
retroperitoneal space. Fifty-five organs were displaced away from renal cell
carcinoma with this technique. The average distance between adjacent
structures and renal cell carcinomas before displacement was 0.36 cm (range,
0.1&ndash;1.0 cm). The average distance between structures and adjacent renal
cell carcinomas after displacement was 1.94 cm (range, 1.1&ndash;4.3 cm)
(<I>p</I> &lt; 0.0001). The average volume of D5W used to achieve organ
displacement was 273.5 mL. No complications were associated with this
technique.</p>
<p><b>CONCLUSION.</b> CT-guided injection of D5W into the retroperitoneum is
an effective method for displacing vital structures away from renal cell
carcinoma.</p>
]]></description>
<dc:creator><![CDATA[Arellano, R. S., Garcia, R. G., Gervais, D. A., Mueller, P. R.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2904</dc:identifier>
<dc:title><![CDATA[Percutaneous CT-Guided Radiofrequency Ablation of Renal Cell Carcinoma: Efficacy of Organ Displacement by Injection of 5% Dextrose in Water Into the Retroperitoneum]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1690</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1686</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1691?rss=1">
<title><![CDATA[Ultrasound-Guided Percutaneous Fine-Needle Aspiration of 545 Focal Pancreatic Lesions]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1691?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to assess the accuracy and
short-term complication rate of ultrasound-guided fine-needle aspiration
cytologic sampling of focal pancreatic lesions.</p>
<p><b>MATERIALS AND METHODS.</b> We reviewed 545 consecutive ultrasound-guided
fine-needle aspiration cytologic sampling procedures for focal pancreatic
lesions from January 2004 through June 2008. The procedures were performed
with a 20- or 21-gauge needle. The onsite cytopathologist evaluated the
appropriateness of the sample and made a diagnosis. We reviewed the final
diagnosis and the radiologic and medical records of all patients for onset of
complications during or within 7 days of the procedure.</p>
<p><b>RESULTS.</b> The study sample included 262 women and 283 men (mean age,
62 years; range, 25&ndash;86 years). The head or uncinate process of the
pancreas was the location of 63.0% of the lesions, and 35.2% of the lesions
were located in the body or tail of the pancreas. The site of 10 lesions
(1.8%) was not specified. Sampling was diagnostic in 509 of the 545 cases
(93.4%). Excluding the 36 nondiagnostic samples, ultrasound-guided fine-needle
aspiration cytologic sampling had 99.4% sensitivity, 100% specificity, and
99.4% accuracy. In 537 of the 545 cases (98.5%), the procedure was uneventful.
In two cases, abdominal fluid was found after the procedure that was not
present before the procedure. Six patients experienced postprocedural pain
without abnormal findings at subsequent imaging. No major complications
occurred.</p>
<p><b>CONCLUSION.</b> Ultrasound-guided cytologic sampling is safe and
accurate for the diagnosis and planning of management of focal pancreatic
lesions. With a cytologist on site, the rate of acquisition of samples
adequate for diagnosis is high, reducing the need for patient recall.</p>
]]></description>
<dc:creator><![CDATA[Zamboni, G. A., D'Onofrio, M., Idili, A., Malago, R., Iozzia, R., Manfrin, E., Mucelli, R. P.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2958</dc:identifier>
<dc:title><![CDATA[Ultrasound-Guided Percutaneous Fine-Needle Aspiration of 545 Focal Pancreatic Lesions]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1695</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1691</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1696?rss=1">
<title><![CDATA[Management of Refractory Hepatic Encephalopathy After Insertion of TIPS: Long-Term Results of Shunt Reduction With Hourglass-Shaped Balloon-Expandable Stent-Graft]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1696?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to review the use of an
hourglass-shaped expanded polytetrafluoroethylene (ePTFE) stent-graft to
reduce transjugular intrahepatic portosystemic shunts in patients with hepatic
encephalopathy refractory to conventional medical therapy.</p>
<p><b>MATERIALS AND METHODS.</b> From January 2000 through December 2008, 189
transjugular intrahepatic portosystemic shunt procedures were performed with
self-expanding stent-grafts. After a mean period of 43.4 &plusmn; 57 weeks,
hepatic encephalopathy developed in 12 patients and did not respond to
conventional medical therapy with lactulose, nonabsorbable antibiotics, and a
protein-restricted diet. In all cases, shunt reduction was performed with an
hourglass-shaped balloon-expandable ePTFE stent-graft inserted into the
original shunt.</p>
<p><b>RESULTS.</b> Technically successful shunt reduction with an immediate
increase in portosystemic gradient was achieved in all patients. Symptoms of
hepatic encephalopathy disappeared a mean of 22.3 hours (range, 18&ndash;26
hours) after the procedure. After a mean follow-up period of 73.9 &plusmn;
61.88 weeks, no recurrence of hepatic encephalopathy was found. One patient
(8.3%) needed dilation of the hourglass-shaped stent-graft after 37 weeks
because of recurrence of ascites. At the end of the study, five patients
(41.6%) were alive in good clinical condition. Four patients (33.3%) died of
cardiovascular failure 1, 2, 24, and 96 weeks after the corrective procedure.
Eight months after the reduction procedure, one patient (8.3%) underwent
orthotopic liver transplantation, which resulted in clinical improvement. Two
patients (16.6%) were lost to follow-up 15.6 and 46.8 weeks after the
procedure.</p>
<p><b>CONCLUSION.</b> Shunt reduction with an hourglass-shaped ePTFE
balloon-expandable stent-graft seems effective in reducing shunt flow and
rapidly improving the patient's clinical condition. With this technique, shunt
diameter can be modified on the basis of the patient's clinical condition.</p>
]]></description>
<dc:creator><![CDATA[Fanelli, F., Salvatori, F. M., Rabuffi, P., Boatta, E., Riggio, O., Lucatelli, P., Passariello, R.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2968</dc:identifier>
<dc:title><![CDATA[Management of Refractory Hepatic Encephalopathy After Insertion of TIPS: Long-Term Results of Shunt Reduction With Hourglass-Shaped Balloon-Expandable Stent-Graft]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1702</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1696</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1703?rss=1">
<title><![CDATA[Percutaneous Intervention of the C2 Vertebral Body Using a CT-Guided Posterolateral Approach]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1703?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to present two cases of
percutaneous biopsy and one case of vertebroplasty of the C2 vertebral body
using a CT-guided posterolateral approach under local anesthesia.</p>
<p><b>CONCLUSION.</b> The CT-guided posterolateral approach was safe,
feasible, and effective for percutaneous intervention of the C2 vertebral
body.</p>
]]></description>
<dc:creator><![CDATA[Sun, H. Y., Lee, J. W., Kim, K.-J., Yeom, J. S., Kang, H. S.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2783</dc:identifier>
<dc:title><![CDATA[Percutaneous Intervention of the C2 Vertebral Body Using a CT-Guided Posterolateral Approach]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1705</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1703</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1708?rss=1">
<title><![CDATA[MRI of the Urethra in Women With Lower Urinary Tract Symptoms: Spectrum of Findings at Static and Dynamic Imaging]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1708?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to determine the findings at
both static and dynamic MRI in women with a clinically suspected urethral
abnormality.</p>
<p><b>MATERIALS AND METHODS.</b> MRI of the urethra was performed in 84 women
with lower urinary tract symptoms using multiplanar T2-weighted turbo
spin-echo and unenhanced and contrast-enhanced gradient-echo sequences. A
dynamic true fast imaging with steady-state free precession sequence was
performed during straining in the sagittal plane. Images were evaluated by two
radiologists for urethral pathology and pelvic organ prolapse. MRI findings
were correlated with clinical symptoms using the Fisher's exact and
Mann-Whitney tests.</p>
<p><b>RESULTS.</b> Urethral abnormalities were found in 10 of 84 patients
(11.9%), including two urethral diverticula, five Skene's gland cysts or
abscesses, and three periurethral cysts. Thirty-three patients (39.3%) were
diagnosed with pelvic organ prolapse, of whom 29 (87.9%) were diagnosed
exclusively on dynamic imaging. In 29 of 33 patients with prolapse (87.9%),
the urethra was structurally normal. MRI showed 13 cystoceles and 17 cases of
urethral hypermobility not detected on physical examination. Patients with a
greater number of vaginal deliveries, stress urinary incontinence, frequency
of voiding, and voiding difficulty were statistically more likely to have
anterior compartment prolapse (<I>p</I> &lt; 0.05).</p>
<p><b>CONCLUSION.</b> Including a dynamic sequence permits both structural and
functional evaluation of the urethra, which may be of added value in women
with lower urinary tract symptoms. Dynamic MRI allows detection of pelvic
organ prolapse that may not be evident on conventional static sequences.</p>
]]></description>
<dc:creator><![CDATA[Bennett, G. L., Hecht, E. M., Tanpitukpongse, T. P., Babb, J. S., Taouli, B., Wong, S., Rosenblum, N., Kanofsky, J. A., Lee, V. S.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1547</dc:identifier>
<dc:title><![CDATA[MRI of the Urethra in Women With Lower Urinary Tract Symptoms: Spectrum of Findings at Static and Dynamic Imaging]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1715</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1708</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1716?rss=1">
<title><![CDATA[Quantitative Diffusion-Weighted Imaging as an Adjunct to Conventional Breast MRI for Improved Positive Predictive Value]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1716?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to investigate whether
adding diffusion-weighted imaging (DWI) to dynamic contrast-enhanced MRI
(DCE-MRI) could improve the positive predictive value (PPV) of breast MRI.</p>
<p><b>MATERIALS AND METHODS.</b> The retrospective study included 70 women
with 83 suspicious breast lesions on DCE-MRI (BI-RADS 4 or 5) who underwent
subsequent biopsy. DWI was acquired during clinical breast MRI using b = 0 and
600 s/mm<sup>2</sup>. Apparent diffusion coefficient (ADC) values were
compared for benign and malignant lesions. PPV was calculated for DCE-MRI
alone (based on biopsy recommendations) and DCE-MRI plus DWI (adding an ADC
threshold) for the same set of lesions. Results were further compared by
lesion type (mass, nonmasslike enhancement) and size.</p>
<p><b>RESULTS.</b> Of the 83 suspicious lesions, 52 were benign and 31 were
malignant (11 ductal carcinoma in situ [DCIS], 20 invasive carcinoma). Both
DCIS (mean ADC, 1.31 &plusmn; 0.24 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;3</sup>
mm<sup>2</sup>/s) and invasive carcinoma (mean ADC, 1.29 &plusmn; 0.29 <FONT FACE="arial,helvetica">x</FONT>
10<sup>&ndash;3</sup> mm<sup>2</sup>/s) exhibited lower mean ADC than benign
lesions (1.70 &plusmn; 0.44 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;3</sup> mm<sup>2</sup>/s,
<I>p</I> &lt; 0.001). Applying an ADC threshold of 1.81 <FONT FACE="arial,helvetica">x</FONT>
10<sup>&ndash;3</sup> mm<sup>2</sup>/s for 100% sensitivity produced a PPV of
47% versus 37% for DCE-MRI alone, which would have avoided biopsy for 33%
(17/52) of benign lesions without missing any cancers. DWI increased PPV
similarly for masses and nonmasslike enhancement and preferentially improved
PPV for smaller (&le; 1 cm) versus larger lesions.</p>
<p><b>CONCLUSION.</b> DWI shows potential for improving the PPV of breast MRI
for lesions of varied types and sizes. However, considerable overlap in ADC of
benign and malignant lesions necessitates validation of these findings in
larger studies.</p>
]]></description>
<dc:creator><![CDATA[Partridge, S. C., DeMartini, W. B., Kurland, B. F., Eby, P. R., White, S. W., Lehman, C. D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2139</dc:identifier>
<dc:title><![CDATA[Quantitative Diffusion-Weighted Imaging as an Adjunct to Conventional Breast MRI for Improved Positive Predictive Value]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1722</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1716</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1723?rss=1">
<title><![CDATA[Short-Term Follow-Up of Palpable Breast Lesions With Benign Imaging Features: Evaluation of 375 Lesions in 320 Women]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1723?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate the feasibility
of short-term follow-up of palpable masses that have benign imaging
features.</p>
<p><b>MATERIALS AND METHODS.</b> The cases of all women with round, oval, or
lobular palpable masses with circumscribed margins and homogeneous ultrasound
echotexture for which short-term follow-up was recommended from July 1997
through December 2003 were retrospectively identified. Evaluation was by
ultrasound and/or mammography and focused clinical examination. Outcome was
assessed with imaging or clinical follow-up lasting at least 12 months. The
cancer incidence for palpable lesions was compared with that for nonpalpable
lesions recommended for short-term follow-up.</p>
<p><b>RESULTS.</b> In 379 women, 443 palpable masses with benign features for
which short-term follow-up was recommended were identified. Outcome data were
available on 375 masses in 320 women. Lesions were evaluated with mammography
and ultrasound (<I>n</I> = 186) or ultrasound alone (<I>n</I> = 189).
Masses were typically identified only with ultrasound (<I>n</I> = 258,
68.8%); were oval (<I>n</I> = 275, 73.3%), of equal density to normal breast
tissue on mammograms (<I>n</I> = 95 on 117 mammograms, 81.2%), and
hypoechoic (<I>n</I> = 336 in 372 ultrasound examinations, 90.3%); and were
prospectively believed to be fibroadenoma (<I>n</I> = 304, 81.1%).
Eighty-five lesions (22.7%) were biopsied soon after evaluation, and one
1.5-mm ductal carcinoma in situ was diagnosed. At follow-up (mean, 2.7 years),
26 lesions (6.9%) had grown. Twenty-four of the 26 lesions were biopsied, and
no cancer was diagnosed. The overall cancer prevalence was similar for
palpable (0.3%) and nonpalpable (1.6%) masses. The cost of short-term
follow-up was less than that of biopsy.</p>
<p><b>CONCLUSION.</b> Short-term follow-up is a reasonable alternative to
biopsy of palpable breast lesions with benign imaging features, particularly
for young women with probable fibroadenoma.</p>
]]></description>
<dc:creator><![CDATA[Harvey, J. A., Nicholson, B. T., LoRusso, A. P., Cohen, M. A., Bovbjerg, V. E.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2811</dc:identifier>
<dc:title><![CDATA[Short-Term Follow-Up of Palpable Breast Lesions With Benign Imaging Features: Evaluation of 375 Lesions in 320 Women]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1730</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1723</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1731?rss=1">
<title><![CDATA[Preoperative Sonographic Classification of Axillary Lymph Nodes in Patients With Breast Cancer: Node-to-Node Correlation With Surgical Histology and Sentinel Node Biopsy Results]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1731?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to prospectively evaluate
the role of axillary lymph node classification by sonography in breast cancer
patients by node-to-node correlation with surgical histology and sentinel node
biopsy results.</p>
<p><b>SUBJECTS AND METHODS.</b> Between June 2006 and December 2006,
preoperative axillary sonography was performed in 191 consecutive breast
cancer patients (median age, 46 years; age range, 24&ndash;79 years) who had
been scheduled to undergo breast cancer surgery with sentinel node biopsy. The
axillary lymph node that had the thickest cortex or that was closest to the
primary tumor was prospectively classified and then removed through
sonographically guided needle localization. Correspondence about and
histologic results for the needle-localized nodes and the radioactive sentinel
nodes were analyzed. The rate of malignancy, according to the sonographic
classification, and the area under a receiver operating characteristic curve
were analyzed.</p>
<p><b>RESULTS.</b> Of the 191 needle-localized nodes, 41 (21%) had metastases
and 150 (79%) did not have metastases. When a cutoff point of a cortical
thickness of 2.5 mm was used, sonographic classification showed 85% (35/41)
sensitivity, 78% (117/150) specificity, and an area under the curve of 0.861
(95% CI, 0.796&ndash;0.926). Of the 54 patients with metastases at sentinel
node biopsy or axillary lymph node dissection, 13 (24%) had false-negative
results of sonographically guided needle localization. Unsuccessful lymphatic
mapping because of absent radiotracer uptake during sentinel node biopsy was
found in 4% (7/191), whereas all needle-localized nodes with a cortical
thickness of more than 2.5 mm were confirmed as metastases.</p>
<p><b>CONCLUSION.</b> Sonographic classification of axillary lymph nodes is
effective for predicting the presence of metastases to avoid sentinel node
biopsy or to reduce unsuccessful lymphatic mapping during sentinel node
biopsy.</p>
]]></description>
<dc:creator><![CDATA[Cho, N., Moon, W. K., Han, W., Park, I. A., Cho, J., Noh, D.-Y.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3122</dc:identifier>
<dc:title><![CDATA[Preoperative Sonographic Classification of Axillary Lymph Nodes in Patients With Breast Cancer: Node-to-Node Correlation With Surgical Histology and Sentinel Node Biopsy Results]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1737</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1731</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1738?rss=1">
<title><![CDATA[Optimal Timing of Breast MRI Examinations for Premenopausal Women Who Do Not Have a Normal Menstrual Cycle]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1738?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to describe a method for
timing breast MRI examinations corresponding to the follicular phase of the
menstrual cycle in premenopausal women without cyclical menses, thereby
reducing the number of false-positive findings and nondiagnostic
examinations.</p>
<p><b>CONCLUSION.</b> Serum progesterone concentrations corresponding to the
follicular phase of a normal menstrual cycle can aid in optimal scheduling of
breast MRI examinations for premenopausal women who lack cyclical menses.</p>
]]></description>
<dc:creator><![CDATA[Ellis, R. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2657</dc:identifier>
<dc:title><![CDATA[Optimal Timing of Breast MRI Examinations for Premenopausal Women Who Do Not Have a Normal Menstrual Cycle]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1740</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1738</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

</rdf:RDF>